TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 130 resultados LastUpdate Última actualización 25/05/2022 [10:40:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 6 nextPage   por página


GLUCOSE SENSORS AND METHODS OF MANUFACTURING

NºPublicación: US2022151521A1 19/05/2022

Solicitante:

CERCACOR LAB INC [US]

Resumen de: US2022151521A1

Embodiments of the present disclosure relate to a temperature independent glucose sensor and methods of making the same. Such glucose monitoring device may comprise a working electrode, a reference electrode, an glucose oxidase containing enzymatic layer, a first permeability-selective layer, an oxygen-replenishing layer, and an outer protective layer. Additional embodiments relate to a glucose sensor having an enzymatic layer containing glucose oxidase and a polymeric mediator. The sensors may be used as an implantable continuous glucose monitoring device without the need of a temperature sensor.

traducir

Onboarding and total daily insulin adaptivity

NºPublicación: AU2020354476A1 19/05/2022

Solicitante:

INSULET CORP

CN_114514583_A

Resumen de: AU2020354476A1

Disclosed are a device, a computer-readable medium, and techniques that provide an onboarding process and an adaptivity process for a drug delivery device. A processor executing an onboarding process determines whether a history of delivered insulin to a user meets certain sufficiency requirements. The onboarding process enables a processor to cause the drug delivery device to administer doses of insulin to a user according to an initial total daily insulin dose calculation that is determined based on the sufficiency of the insulin delivery history. The initial total daily insulin may be adapted according to the adaptivity process as new insulin delivery is collected. The insulin delivery history, when sufficient, may be used to set total daily insulin dosages that enable automated insulin delivery upon replacement of a drug delivery device. The adaptivity process may be implemented to modify an initial insulin delivery doses to provide adapted insulin delivery doses.

traducir

Non-invasive determination of glucose

NºPublicación: AU2020360444A1 19/05/2022

Solicitante:

GLUCO TERA TECH AG

AU_2020360024_A1

Resumen de: AU2020360444A1

The present invention relates to the non-invasive determination of glucose in blood, in particular to the non-invasive determination of glucose in capillary blood.

traducir

DEVICE FOR MEASURING NERVE CONDUCTION FOR EARLY DETECTION OF DIABETIC NEUROPATHY

NºPublicación: AU2021104163A4 19/05/2022

Solicitante:

CHARAN C S [IN]
K HANUMANTHACHAR JOSHI [IN]
KOSEY SOURABH [IN]
P SANDHYA [IN]
SAXENA BHAGAWATI [IN]
UPASANI CHANDRASHEKHAR D [IN]
WAL PRANAY [IN]

Resumen de: AU2021104163A4

Disclosed herein a device and method for performing the sural nerve conduction test to accurately assess the nerve damage for early detection of Diabetic Peripheral Neuropathy (DPN) by measuring the onset sural nerve conduction velocity, sensory response amplitude The device compares the measured nerve parameters with standard data to calculate the nerve damage and displays the result in a display unit. For conducting the test, a cuff is wrapped over the leg of the patient to determine the exact location of the sural nerve region and contains an array of simulation electrodes that can send the electrical pulses to the wide area of sural nerve / muscle region and a wide array of bio-sensing electrodes for sensing and signal acquisition. DRAWINGS: FIG. 1 is a flowchart representing the working methodology of the device of the present invention. Electrical Pulse input from the device to muscle/ sural nerve Bio-Potential Signal Signal Processing for DAC & Generate Signal Acquisitio Manipulation & 10 NCV and Muscle 10 Output Signal for s -onHADC Parameter Calculation Display Display Device FIG. 2 is a block diagram representing the simulation unit of the device of the present invention. Power ON/OFF Battery Box Microcontraller To-Simulation Timing Circuit electrodes

traducir

MEASURING DEVICE FOR DETERMINING THE BLOOD SUGAR CONTENT

NºPublicación: US2022151520A1 19/05/2022

Solicitante:

GERICKE ESTERMANN MONIKA [CH]
TURKOVSKI IVAN IVANOWITSCH [CH]

DE_102019103641_A1

Resumen de: US2022151520A1

A measuring device for determining an estimated value for the blood sugar content of a person using a non-invasive impedance measurement is provided. The measuring device includes a measurement transducer for determining a blood sugar content from a measured value and a sensor unit for detecting the measured value. The sensor unit has at least two tetrapolar electrode assemblies, which each have at least two electrode pairs arranged along a first linear axis. The axes of the two tetrapolar electrode assemblies are aligned perpendicularly to one another. A first electrode pair is provided for transmitting and receiving a current signal, and a second electrode pair is provided for tapping a potential on contact with the skin of the person. At least one of the electrodes of the sensor unit has a contact surface for contacting the skin, which contact surface consists of a metal or a metal alloy having a conductivity of more than 1*107 S/m.

traducir

Systems and methods for health data visualization and user support tools for continuous glucose monitoring

NºPublicación: AU2022202750A1 19/05/2022

Solicitante:

DEXCOM INC [US]

US_2022000432_A1

Resumen de: AU2022202750A1

Disclosed are systems and methods for generating graphical displays of analyte data and/or health information. In some implementations, the graphical displays are generating based on a self-referential dataset that are modifiable based on identified portions of the data. The modified graphical displays can indicate features in the analyte data of a host.

traducir

SMART BRACELET DEVICE CONTAINING GLUCOSE AND/OR GLUCAGON

NºPublicación: WO2022101865A1 19/05/2022

Solicitante:

CUCCHIARELLI CRISTINA [IT]

Resumen de: WO2022101865A1

"Smart bracelet device containing glucose and/or glucagon" Ergonomic, wearable smart device, containing predetermined quantities of glucose and/or glucagon adapted to restore the concentration of glucose in the blood comprising: - a body of the device (1) with tubular shape containing predetermined quantities of glucose and/or glucagon; - a reload valve (4) housing at least a lip (6.1) of a reload cartridge (6), adapted to restore the reserves of glucose and/or glucagon; - a straw (3), a nasal spray (11) or both adapted for the consumption of a predetermined quantity of glucose and/or glucagon; - a smart valve (2) adapted to receive information regarding the exact quantity to be administered; - a magnetic closure (5); - a reload cartridge (6) comprising a tank (6.2) and a lip (6.1); - a display (7); - a glycemia detector (8) adapted to check the quantity of glucose in the blood, adapted to interact with said display (7) with latest-generation cellular device, CGM, insulin pumps.

traducir

METHOD AND SYSTEM FOR DETERMINING GLUCOSE CHANGE IN A SUBJECT

NºPublicación: EP3997712A1 18/05/2022

Solicitante:

LILLY CO ELI [US]

CN_114127860_PA

Resumen de: WO2021005552A1

There is provided a method and a system for determining glucose change in a subject, which includes receiving subject model parameters. The subject model parameters of a state-based model of the subject may have been estimated based on: actual glucose measurements and past subject model parameters. An innovation parameter and an innovation covariance parameter are determined using a Kalman filter based on the subject model parameters and a previous state of the subject. A test statistic is calculated based on the determined innovation parameter and the innovation covariance parameter. The calculated test statistic is compared to a given threshold. In response to the calculated test statistic being above the given threshold, an indication of the glucose change is outputted.

traducir

BLOOD SUGAR TESTING INSTRUMENT WITH HYGROSCOPIC DISPLAY

NºPublicación: PL3844490T3 16/05/2022

Solicitante:

XGLU LABS A S [CZ]

DIABETES THERAPY BASED ON DETERMINATION OF FOOD ITEM

NºPublicación: US2022143314A1 12/05/2022

Solicitante:

MEDTRONIC MINIMED INC [US]

CN_114446493_A

Resumen de: US2022143314A1

Devices, systems, and techniques for guiding therapy delivery to a diabetes patient is described. Some devices, systems, and techniques proactively monitor the patient's food consumption and (if needed) adapt the patient's diabetes therapy accordingly. In one example, a system comprises one or more sensors configured to capture a representation of the object, and processing circuitry configured to determine data corresponding to the representation of the object, wherein the data comprises information identifying the object as a particular food item; generate food item information based on the information identifying the object as the particular food item, wherein the food item information comprises at least one of nutrition information or volume information of the particular food item, generate therapy information for the patient based on the food item information, and output content indicative of at least one of the therapy information or the food item information.

traducir

METHOD AND DEVICES FOR ANALYTE MONITORING CALIBRATION

NºPublicación: US2022142519A1 12/05/2022

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2021030318_A1

Resumen de: US2022142519A1

Methods, systems and devices for providing improved calibration accuracy of continuous and/or in vivo analyte monitoring systems based at least in part on insulin delivery information are provided. Many of the embodiments disclosed herein can determine appropriate conditions for performing a calibration of the analyte sensor in view of the scheduled delivery of insulin or administered insulin amount. One or more other parameters or conditions can also be incorporated to improve calibration accuracy including, for example, the physiological model associated with a patient, meal information, exercise information, activity information, disease information, historical physiological condition information, as well as other types of information. Furthermore, according to some embodiments, calibration of the analyte sensor can be delayed or not performed at all, if appropriate conditions are not met.

traducir

APPARATUS AND METHOD FOR CREATING A STABLE OPTICAL INTERFACE

NºPublicación: US2022142517A1 12/05/2022

Solicitante:

MASIMO CORP [US]

US_2019216370_A1

Resumen de: US2022142517A1

A system and a method for creating a stable and reproducible interface of an optical sensor system for measuring blood glucose levels in biological tissue include a dual wedge prism sensor attached to a disposable optic that comprises a focusing lens and an optical window. The disposable optic adheres to the skin to allow a patient to take multiple readings or scans at the same location. The disposable optic includes a Petzval surface placed flush against the skin to maintain the focal point of the optical beam on the surface of the skin. Additionally, the integrity of the sensor signal is maximized by varying the rotation rates of the dual wedge prisms over time in relation to the depth scan rate of the sensor. Optimally, a medium may be injected between the disposable and the skin to match the respective refractive indices and optimize the signal collection of the sensor.

traducir

SYSTEMS AND METHODS FOR DETECTING GLUCOSE METABOLISM BY A PATIENT

NºPublicación: US2022142567A1 12/05/2022

Solicitante:

GE PREC HEALTHCARE LLC [US]

CN_114451881_A

Resumen de: US2022142567A1

A method for detecting a metabolism of glucose by a patient. The method includes producing a magnetic field that acts upon the patient, then acquiring magnetic resonance data of deuterated water within the patient, where deuterated glucose has been administered to the patient, where the deuterated water is produced during the metabolism of the deuterated glucose by the patient, and where the magnetic resonance data is acquired at a resonant frequency of deuterium. The method further includes analyzing the magnetic resonance data acquired at the resonant frequency of deuterium, non-spectrally resolved, to generate a processed dataset. The method further includes constructing an image based on the processed dataset, where the metabolism of the glucose by the patient is detected via the constructed image.

traducir

FLEXIBLE SENSOR DETECTION SYSTEM FOR MEDICAL CARE AND HEALTH

NºPublicación: US2022142573A1 12/05/2022

Solicitante:

UNIV QINGDAO TECHNOLOGY [CN]
NINGBO SANHAN ALLOY MAT CO LTD [CN]

WO_2021134858_A1

Resumen de: US2022142573A1

The present invention discloses a flexible sensor detection system for medical care and health, including: an information collection module, which uses a wearable device as a carrier, where flexible sensors are respectively arranged on the wearable device; an information transmission module, configured to wirelessly transmit collected information to an information processing and feedback module; and the information processing and feedback module, configured to perform grading treatment on received data information and feed back a health condition corresponding to the data information to the information transmission module, where the information transmission module compares feedback health condition data with a preset health threshold to determine whether to give an alarm. A heart rate ECG band, a breathing band, a shell temperature band, a blood flow rate band, a blood glucose band, a blood oxygen band, and a deep temperature band of the present invention are provided with the built-in flexible sensors.

traducir

Diabetes Management Therapy Advisor

NºPublicación: US2022148742A1 12/05/2022

Solicitante:

ASEKO INC [US]

US_2019326005_A1

Resumen de: US2022148742A1

A method includes obtaining training data for a plurality of patients of a patient population. The training data includes training blood glucose history data including treatment doses of insulin administered by the patients of the patient population and one or more outcome attributes associated with each treatment dose. The method also includes identifying, for each patient of the patient population, one or more optimum treatment doses of insulin from the treatment doses yielding favorable outcome attributes. The method also includes receiving patient-state information for the treated patient, determining a next recommended treatment dose of insulin for the treated patient based on one or more of the identified optimum treatment doses associated with the patients of the patient population having training patient-state information similar to the patient-state information for the treated patient, and transmitting the next recommended treatment dose to a portable device associated with the treated patient.

traducir

PHOTOACOUSTIC DIAGNOSTIC DEVICE AND METHOD

NºPublicación: WO2022098128A1 12/05/2022

Solicitante:

HME SQUARE CO LTD [KR]

Resumen de: WO2022098128A1

The present invention relates to a photoacoustic diagnostic device and method for measuring a blood glucose level by measuring shape changes of membranes caused by a sound wave, and more specifically, to a photoacoustic diagnostic device and method capable of regulating a frequency response of a diagnostic device by regulating the sizes of membranes. The photoacoustic diagnostic device according to one embodiment of the present invention comprises: a light source irradiating a subject with light to radiate a sound; a plurality of sound pickup units provided with membranes whose shapes change by the sound; and a measurement unit which measures a shape change of the membrane, wherein the membranes of the plurality of sound pickup units may have different sizes from one another.

traducir

A NON-INVASIVE GLUCOMETER

NºPublicación: US2022142520A1 12/05/2022

Solicitante:

BIOFI MEDICAL HEALTHCARE INDIA PRIVATE LTD [IN]
BIOFI MEDICAL HEALTHCARE INDIA PVT LTD [IN]

WO_2020183497_A1

Resumen de: US2022142520A1

A glucometer for monitoring blood glucose comprises a curved test surface with a transparent test site. The curved test surface accommodates a finger-tip and an enclosing lid encloses the finger-tip when it is placed on the transparent test site. The glucometer further comprises a light source assembly comprising light emitting diodes, underneath the transparent test site. The glucometer further comprises detectors for detecting transflective light, transmissive light, and reflective light from blood capillaries at a depth of 100 micro meters below skin surface. The glucometer further comprises a software module comprising a first sub-module that comprises a first set of algorithms for generating a data matrix. The transflective, transmissive light, and reflective light from blood capillaries are measured and recorded in data matrix. A second sub-module comprises a second set of algorithms for non-invasive measurement of concentration of glucose in the blood by processing data within the data matrix.

traducir

RAPID ESTABLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STEADY-STATE DRUG DELIVERY

NºPublicación: AU2022202622A1 12/05/2022

Solicitante:

INTARCIA THERAPEUTICS INC [US]

US_2021236413_A1

Resumen de: AU2022202622A1

The present invention is directed to treatment methods for a disease or condition, in a subject in need of such treatment, that provide alternatives to treatment by injection that give, relative to treatment by injection, improved treatment outcomes, 100% treatment compliance, reduced side effects, and rapid establishment and/or termination of substantial steady-state drug delivery. The method typically includes providing continuous delivery of a drug from an implanted osmotic delivery device, wherein substantial steady-state delivery of the drug at therapeutic concentrations is typically achieved within about 7 days or less after implantation of the osmotic delivery device in the subject and the substantial steady-state delivery of the drug from the osmotic delivery device is continuous over a period of at least about 3 months. In one embodiment, the present invention is directed to treatment of type 2 diabetes mellitus using incretin mimetics.

traducir

INSULIN LARGE-DOSE INFUSION CONTROL METHOD AND APPARATUS, SYSTEM, AND INSULIN PUMP APPARATUS

NºPublicación: WO2022095994A1 12/05/2022

Solicitante:

MICROTECH MEDICAL HANGZHOU CO LTD [CN]

CN_112516408_A

Resumen de: WO2022095994A1

Disclosed in the present invention are an insulin large-dose infusion control method and apparatus, a system, and an insulin pump apparatus, being helpful for improving the safety and reliability of an insulin large-dose infusion process. An infusion system comprises a controller and an insulin pump used for infusion; the controller is used for controlling, upon receiving an insulin large-dose infusion instruction, the insulin pump to perform infusion, obtaining an insulin large-dose infusion historical record saved by the insulin pump, determining, according to a latest historical record saved by the insulin pump, whether the insulin pump is performing infusion, and according to a determination result, outputting prompt information; and the insulin pump is used for performing insulin infusion and saving the insulin large-dose infusion historical record of the insulin pump.

traducir

CONTACTLESS DEVICE FOR MEASURING BLOOD SUGAR

NºPublicación: EP3994763A1 11/05/2022

Solicitante:

MARGGRAF [FR]
UNIV DE LORRAINE [FR]

WO_2021001476_A1

Resumen de: WO2021001476A1

Device for measuring blood glucose in a live subject, comprising an antenna (1) intended to be placed close to the live subject, an electronic unit (2) for supplying power to the antenna (1) and measuring a feedback signal from the antenna (1). The antenna (1, 1') comprises: - a transmission line (10, 10') which extends over a first surface (11) or a second surface (12) of a flat dielectric substrate and is connected to the electronic unit (2); - an earth plane (13) extending over at least one part of the second surface (12) of the substrate; - at least one resonator (14) extending over the first surface (11) close to the transmission line (10, 10'); the electronic unit (2) being provided to supply the antenna (1) with a signal at a predetermined frequency of between 0.9 and 1.6 GHz, measure a feedback signal, determine the electrical characteristics of the antenna (1) and infer a blood glucose level in the live subject therefrom.

traducir

DIABETES THERAPY BASED ON DETERMINATION OF FOOD ITEMS

NºPublicación: EP3996100A1 11/05/2022

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2022143314_A1

Resumen de: EP3996100A1

Devices, systems, and techniques for guiding therapy delivery to a diabetes patient is described. Some devices, systems, and techniques proactively monitor the patient's food consumption and (if needed) adapt the patient's diabetes therapy accordingly. In one example, a system comprises one or more sensors configured to capture a representation of the object, and processing circuitry configured to determine data corresponding to the representation of the object, wherein the data comprises information identifying the object as a particular food item; generate food item information based on the information identifying the object as the particular food item, wherein the food item information comprises at least one of nutrition information or volume information of the particular food item, generate therapy information for the patient based on the food item information, and output content indicative of at least one of the therapy information or the food item information.

traducir

Contactless photoplethysmography for physiological parameter measurement

NºPublicación: US11324406B1 10/05/2022

Solicitante:

UNIV KING ABDULAZIZ [SA]

Resumen de: US11324406B1

Provided are systems and methods for determining a subject's physiological parameters such as heart rate, blood glucose level, variation in heart rate and/or oxygen saturation in a non-contact manner. A photoplethysmography (PPG) signal representing physiological parameter is obtained from a subject by a sensor that generates non-contact PPG signal in red, blue, green (RBG) components. The method further includes a step of analyzing the RBG components for simultaneously measuring the oxygen saturation level and any of the heart rate, blood glucose level or variation in heart rate of the subject.

traducir

ACTIVE MINIATURIZED SENSING SYSTEM

NºPublicación: WO2022090503A1 05/05/2022

Solicitante:

GLUCOMAT GMBH [DE]

Resumen de: WO2022090503A1

The present invention relates to a non-invasive active sensing system for determining a physiological parameter in a bodily fluid of subject, especially for determining glucose in blood. Further, the present invention relates to a non-invasive method for determining a physiological parameter in a bodily fluid of a subject. The system and method involve irradiating with visual or near-IR radiation and detecting emitted IR radiation in a mid-IR/far-IR range.

traducir

GLUCOSE BIOSENSORS COMPRISING DIRECT ELECTRON TRANSFER ENZYMES AND METHODS OF MAKING AND USING THEM

NºPublicación: WO2022093574A1 05/05/2022

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2022133190_A1

Resumen de: WO2022093574A1

Embodiments of the invention provide constellations of elements useful in glucose sensors as well as methods for making and using such glucose sensors. In typical embodiments of the invention, the sensor is a glucose sensor for diabetics that comprises an analyte sensing membrane formed from a layered stack of material that includes a cellobiose dehydrogenase enzyme composition disposed over an electrode that is further coated with an analyte modulating layer formed from a cellulose acetate composition.

traducir

GLUCOSE BIOSENSORS COMPRISING DIRECT ELECTRON TRANSFER ENZYMES AND METHODS OF MAKING AND USING THEM

Nº publicación: US2022133190A1 05/05/2022

Solicitante:

MEDTRONIC MINIMED INC [US]

WO_2022093574_A1

Resumen de: US2022133190A1

Embodiments of the invention provide constellations of elements useful in glucose sensors as well as methods for making and using such glucose sensors. In typical embodiments of the invention, the sensor is a glucose sensor for diabetics that comprises an analyte sensing membrane formed from a layered stack of material that includes a cellobiose dehydrogenase enzyme composition disposed over an electrode that is further coated with an analyte modulating layer formed from a cellulose acetate composition.

traducir

Página1 de 6 nextPage por página

punteroimgVolver